Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 118077362 | 11807736 | 2 | F | 20160720 | 20151207 | 20160722 | PER | US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-082215 | BRISTOL MYERS SQUIBB | 44.00 | YR | F | Y | 0.00000 | 20160722 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 118077362 | 11807736 | 1 | PS | ABILIFY | ARIPIPRAZOLE | 1 | Unknown | 5 MG, QD | N | 21436 | 5 | MG | QD | ||||||
| 118077362 | 11807736 | 2 | SS | ABILIFY | ARIPIPRAZOLE | 1 | N | 21436 | |||||||||||
| 118077362 | 11807736 | 3 | C | EFFEXOR | VENLAFAXINE HYDROCHLORIDE | 1 | Unknown | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 118077362 | 11807736 | 1 | Bipolar disorder |
| 118077362 | 11807736 | 2 | Depression |
| 118077362 | 11807736 | 3 | Product used for unknown indication |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 118077362 | 11807736 | Hypocalcaemia | |
| 118077362 | 11807736 | Presyncope | |
| 118077362 | 11807736 | Weight decreased | |
| 118077362 | 11807736 | Weight increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 118077362 | 11807736 | 1 | 2010 | 201502 | 0 |